发明申请
US20120172359A1 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
审中-公开
恶嗪衍生物及其在神经障碍治疗中的应用
- 专利标题: Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
- 专利标题(中): 恶嗪衍生物及其在神经障碍治疗中的应用
-
申请号: US13414440申请日: 2012-03-07
-
公开(公告)号: US20120172359A1公开(公告)日: 2012-07-05
- 发明人: Sangamesh BADIGER , Murali CHEBROLU , Mathias FREDERIKSEN , Philipp HOLZER , Konstanze HURTH , Rainer Martin LUEOEND , Lei LI , Hui LIU , Rainer MACHAUER , Henrik MOEBITZ , Ulf NEUMANN , Rita RAMOS , Heinrich RUEEGER , Michael SCHAEFER , Siem Jacob VEENSTRA , Marina TINTELNOT-BLOMLEY , Markus VOEGTLE , Xin XIONG
- 申请人: Sangamesh BADIGER , Murali CHEBROLU , Mathias FREDERIKSEN , Philipp HOLZER , Konstanze HURTH , Rainer Martin LUEOEND , Lei LI , Hui LIU , Rainer MACHAUER , Henrik MOEBITZ , Ulf NEUMANN , Rita RAMOS , Heinrich RUEEGER , Michael SCHAEFER , Siem Jacob VEENSTRA , Marina TINTELNOT-BLOMLEY , Markus VOEGTLE , Xin XIONG
- 申请人地址: CH Basel
- 专利权人: NOVARTIS AG
- 当前专利权人: NOVARTIS AG
- 当前专利权人地址: CH Basel
- 优先权: EPPCT/EP2010/060718 20100723; CNPCT/CN2011/077119 20110713
- 主分类号: A61K31/5377
- IPC分类号: A61K31/5377 ; A61P25/18 ; A61P25/00 ; A61P35/00 ; A61P25/22 ; A61P25/08 ; A61P25/06 ; A61P25/24 ; A61P25/28 ; A61P29/00 ; A61P17/04 ; A61P1/08 ; A61P3/04 ; A61P21/02 ; A61P27/16 ; A61P27/06 ; A61P25/30 ; C07D413/12
摘要:
The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their medical use and to medicaments comprising them.
信息查询
IPC分类: